AllCells, LLC Sustainability Profile
AllCells, LLC, headquartered in the United States, is a leading provider of high-quality human primary cells and related products for the life sciences industry. Founded in 1998, the company has established itself as a trusted partner for researchers and organisations in fields such as drug discovery, regenerative medicine, and cell therapy. With operational facilities across key regions in the US, AllCells offers a diverse range of core products, including human peripheral blood mononuclear cells (PBMCs), primary cell types, and custom cell solutions. What sets AllCells apart is its commitment to quality and customer service, ensuring that clients receive the most reliable and ethically sourced biological materials. Recognised for its innovation and expertise, AllCells continues to strengthen its market position, contributing significantly to advancements in biomedical research and therapeutic development.
DitchCarbon Score
How does AllCells, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AllCells, LLC's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AllCells, LLC's reported carbon emissions
AllCells, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Discovery Life Sciences, Inc., which may influence its climate commitments and reporting practices. While AllCells has not established specific reduction targets or initiatives, it is important to note that its parent company, Discovery Life Sciences, Inc., may have its own sustainability goals and strategies that could impact AllCells' future climate commitments. As of now, there are no publicly available details regarding Science-Based Targets Initiative (SBTi) commitments or other climate pledges. In the context of the industry, many organisations are increasingly focusing on reducing their carbon footprints and enhancing sustainability practices. AllCells, as part of this evolving landscape, may look to align with broader industry standards and expectations in the future.
How Carbon Intensive is AllCells, LLC's Industry?
How Carbon Intensive is AllCells, LLC's Location?
AllCells, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AllCells, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
